Department of Cardiology, Geisinger Medical Center, Danville, PA, USA.
Am J Cardiol. 2013 Mar 1;111(5):661-6. doi: 10.1016/j.amjcard.2012.11.015. Epub 2012 Dec 19.
A slow, steady heart rate (HR) is necessary for optimal image quality during coronary computed tomographic angiography. Beta blockers are often used, but the goal HR is not achieved in some patients. The aim of this study was to examine the influence of single-nucleotide polymorphisms (SNPs) of the β(1) (codons 49 and 389) and β(2) (codons 16, 27, and 164) adrenergic receptor (AR) genes on HR response to metoprolol in 200 adults (mean age 56 ± 11 years) referred for coronary computed tomographic angiography (using a 64-slice scanner). Oral and intravenous (IV) metoprolol was given to achieve a goal HR of <60 beats/min. Overall, 37 patients (18.5%) did not reach the goal HR despite the administration of oral (181 ± 116 mg) and IV (4.2 ± 9.4 mg) metoprolol. Patients with the β(1)-AR Ser49Gly or Gly49Gly genotype (n = 49) more often failed to reach an optimal HR compared to those with the Ser49Ser genotype (n = 151) (29% vs 15%, p = 0.04), despite receiving higher doses of oral (210 ± 115 vs 172 ± 115 mg, p = 0.048) and IV (7 ± 13 vs 3 ± 8 mg, p = 0.02) metoprolol. Similarly, patients with the β(1)-AR Gly389Gly genotype (n = 11) more often failed to reach an optimal HR compared to those with the Arg389Arg and Arg389Gly genotypes (n = 189) (45% vs 17%, p = 0.02), despite receiving higher doses of IV (13 ± 15 vs 4 ± 9 mg, p = 0.002) but not oral (162 ± 105 vs 182 ± 117 mg, p = 0.50) metoprolol. Multivariate analysis identified β(1)-AR SNPs at codons 49 and 389 and β(2)-AR SNP at codon 27 as independent predictors of suboptimal HR response. In conclusion, these data indicate that the selected SNPs of β(1)-AR and β(2)-AR genes influence HR response to metoprolol in patients who undergo coronary computed tomographic angiography.
静息心率(HR)缓慢而稳定是进行冠状动脉计算机断层扫描血管造影术(CCTA)获得最佳图像质量的必要条件。常使用β受体阻滞剂,但部分患者的目标 HR 仍无法达到。本研究的目的是探讨β1(密码子 49 和 389)和β2(密码子 16、27 和 164)肾上腺素能受体(AR)基因的单核苷酸多态性(SNP)对 200 名接受 CCTA 检查(使用 64 层扫描仪)的成年人应用美托洛尔后 HR 反应的影响。口服和静脉(IV)给予美托洛尔,以达到<60 次/分钟的目标 HR。总的来说,尽管给予了口服(181±116mg)和 IV(4.2±9.4mg)美托洛尔,但仍有 37 例(18.5%)患者的 HR 未达到目标。与 Ser49Ser 基因型(n=151)相比,β1-AR Ser49Gly 或 Gly49Gly 基因型(n=49)的患者更常无法达到理想的 HR(29%比 15%,p=0.04),尽管他们接受了更高剂量的口服(210±115 比 172±115mg,p=0.048)和 IV(7±13 比 3±8mg,p=0.02)美托洛尔。同样,与 Arg389Arg 和 Arg389Gly 基因型(n=189)相比,β1-AR Gly389Gly 基因型(n=11)的患者更常无法达到理想的 HR(45%比 17%,p=0.02),尽管他们接受了更高剂量的 IV(13±15 比 4±9mg,p=0.002)美托洛尔,但未接受更高剂量的口服(162±105 比 182±117mg,p=0.50)美托洛尔。多变量分析确定β1-AR 密码子 49 和 389 以及β2-AR 密码子 27 的 SNP 是 HR 对美托洛尔反应不佳的独立预测因子。结论:这些数据表明,β1-AR 和β2-AR 基因的选定 SNP 影响接受 CCTA 检查的患者对美托洛尔的 HR 反应。